Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Robert A. Rostock"'
Autor:
Irina Kapitanova, Sharmi Biswas, Sabrina Divekar, Eric J. Kemmerer, Robert A. Rostock, Kenneth M. Forster, Rachel J. Grimm, Carla J. Scofield, Jimm Grimm, Bahman Emami, Anand Mahadevan
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-13 (2021)
Abstract Background Brachial plexopathy is a potentially serious complication from stereotactic body radiation therapy (SBRT) that has not been widely studied. Therefore, we compared datasets from two different institutions and generated a brachial p
Externí odkaz:
https://doaj.org/article/b873e39572634ac6aab52c7de1f01ff5
Autor:
Organization: Klaus Kisters (Herne/Bochum), Thomas Noack (Rostock), Robert Patejdl (Rostock), null Germany
Publikováno v:
Trace Elements and Electrolytes. 39:158-162
Autor:
Kenneth M. Forster, Anand Mahadevan, Sabrina Divekar, Sharmi Biswas, Robert A Rostock, Jimm Grimm, Irina Kapitanova, Carla J Scofield, Rachel J Grimm, Bahman Emami, Eric Kemmerer
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-13 (2021)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
Background Brachial plexopathy is a potentially serious complication from stereotactic body radiation therapy (SBRT) that has not been widely studied. Therefore, we compared datasets from two different institutions and generated a brachial plexus dos
Autor:
Sucha O. Asbell, Tamara A. LaCouture, James S. Welsh, Jimm Grimm, Ian J. Butterwick, Lawrence Kleinberg, Carla J Scofield, Alexander Muacevic, Anand Mahadevan, Kristin J. Redmond, John R. Adler, Robert A Rostock, Bahman Emami, Eric Kemmerer, Jason Stanford, Jinyu Xue, Kenneth M. Forster, Sunjay Shah
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2021)
Frontiers in Oncology, Vol 10 (2021)
ObjectiveTo determine the long-term normal tissue complication probability with stereotactic body radiation therapy (SBRT) treatments for targets that move with respiration and its relation with the type of respiratory motion management (tracking vs.
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 10:1135-1141
Polyclonal 131I rabbit anti-rat ferritin localizes in the H-4-II-E hepatoma model. The effect of tumor size, vascularity, and ferritin content on tumor localization was examined. The extravascular and intravascular quantity and location of 131I non-s
Autor:
Robert A. Rostock, Raymond E. Lenhard, Stanley E. Order, Moody D. Wharam, Stanley S. Siegelman, A. Giangreco
Publikováno v:
Cancer. 49:2267-2275
Seventy-one patients with Hodgkin's disease who were initially treated at Johns Hopkins with radiation or radiation-chemotherapy from 1975--1980 had a five-year cumulative disease-free survival of I-A--100% (12 patients); II-A--85% (33 patients); II-
Autor:
Melvyn P. Richter, Morton M. Kligerman, Leo F. Poyss, Debbie A. Zekoski, Jeffrey M. Zero, Michael Gallagher, Harmar D. Brereton, Robert A. Rostock
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 12:1565-1573
The volume, distribution, and mobility of opacified pelvic small bowel (PSB) were determined by fluoroscopy and orthogonal radiographs in 150 consecutive patients undergoing pelvic irradiation. Various techniques including uteropexy, omental transpos
Publikováno v:
RadioGraphics. 6:475-502
CT of the axilla is useful in evaluating a palpable mass or brachial plexopathy, staging a known malignant neoplasm and evaluating a radiation therapy port.
Publikováno v:
Human Pathology. 15:147-152
The clinical and morphologic features of four cases of spindle cell carcinoma of the breast are presented, and the comparable features of 35 previously reported cases are reviewed. All tumors contained histologically malignant squamous carcinoma that
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 11:1413-1418
One hundred forty-five patients with hepatoma had CT scanning for radiation therapy treatment planning. In order to demonstrate the anatomical distortions that occur with hepatoma and its effect on treatment planning, a control group of 50 colorectal